Pharmaceutical Needs Assessment (PNA) 2015 – 2019 Solihull
Total Page:16
File Type:pdf, Size:1020Kb
Solihull Pharmaceutical Needs Assessment 2015 – 2019 Pharmaceutical Needs Assessment (PNA) 2015 – 2019 Solihull V.02 DRAFT The data contained in this document is considered correct at the time of preparation Date prepared: 09th February, 2015 Date of publication: Date of review: 1 Solihull Pharmaceutical Needs Assessment 2015 – 2019 Thank you to the following in helping to compile the Pharmaceutical Needs Assessment: Gurjinder Samra Author & Medicines Management Midlands & Lancashire Pharmacist Commissioning Support Unit Angela Collard Public Health Epidemiologist Solihull Public Health Preetpal Channa Comms & Engagement Specialist Midlands & Lancashire Commissioning Support Unit Jonathan Horgan Project Sponsor Midlands & Lancashire Commissioning Support Unit Christine de Comms & Engagement Lead Midlands & Lancashire Souza Commissioning Support Unit Stephen Munday Director of Public Health Solihull Public Health Donna Vines PA to Director of Public Health Solihull Public Health Len Dalton Chair Solihull Local Pharmaceutical Committee Phil Maslin Communications Lead Solihull Local Pharmaceutical Committee Kate Arnold Medicines Management Lead Solihull CCG This document is an update to the former Solihull PCT’s PNA document. We would like to acknowledge the authors of the Solihull PNA 2011 document. Please note data regarding pharmacies is accurate to November 2014. This document has been developed by Midlands & Lancashire Commissioning Support Unit with Public Health of Solihull Metropolitan Borough Council. Midlands and Lancashire CSU www.midlandsandlancashirecsu.nhs.uk Kingston House 438-450 High Street West Midlands B70 9LD 2 Solihull Pharmaceutical Needs Assessment 2015 – 2019 CONTENTS ABBREVIATIONS & GLOSSARY FOREWORD 1. EXECUTIVE SUMMARY 1.1. Overview 1.2. Access 1.3. Services 1.4. Conclusion 2. INTRODUCTION 2.1. Solihull Health and Wellbeing Board 2.2. Solihull CCG 2.3. Pharmaceutical needs assessment 3. CONTEXT FOR THE PNA 3.1. The evolution of PNA’s 3.2. The scope of the PNA and what is excluded 3.2.1 Pharmaceutical providers 3.2.2 Essential Services 3.2.3 Advanced Services 3.2.4 Enhanced Services 3.2.5 What is excluded from the scope of the PNA 3.3. Circumstances under which the PNA is updated or amended 3.4. Future Housing Developments 4. THE PNA DEVELOPMENT PROCESS 4.1. Determining Localities 4.2. Governance and steering group 4.3. Information Sources 4.4. Stages of development of PNA 4.5. Equality Assessment 4.6. Process of formal consultation 5. Description of Solihull 5.1. Solihull in Context and the JSNA 5.2. Solihull Population Demography 5.3. Age profile 5.4. Population structure by locality 5.5. Population forecast 5.6. Forecast change in population structure 3 Solihull Pharmaceutical Needs Assessment 2015 – 2019 5.7. Ethnicity 5.8. Deprivation 5.9. Life Expectancy 5.10. Infant Mortality 5.11. Disease Prevalence 5.12. Hospital admissions 5.13. Smoking 5.14. Alcohol 6. Surveys for information gathering 6.1. Pharmacy Survey Overview 6.2 Pharmacy Survey analysis & key findings 6.3 Patient Survey Overview 6.4 Patient Survey respondent profile 6.4.1 Location of Respondents & Use of Pharmacies 6.4.2 Demographics of respondents 6.5 Patient Survey analysis & key findings 7. Current Pharmacy Provision and Assessment 7.1. Essential services 7.2. Benchmarking Provision of Pharmacy Services 7.3. Analysis of opening hours 7.3.1 100 hour contracts and extended opening hour pharmacies 7.3.2 Saturday Opening Hours 7.3.3 Sunday Opening Hours 7.3.4 Bank Holiday Provision 7.3.5 Provision of dispensing services 7.3.6 Out of Hours Service Provision 7.3.7 Walk in Centres 7.3.8 Cross Border Dispensing 7.4. Distance selling Pharmacy 7.5. Advanced Services 7.5.2 Premises and Consultation areas 7.5.3 Medicines Use Review 7.5.4 Appliance Use Review 7.5.5 New Medicine Service 7.5.6 Stoma Appliance Review Service 7.6. Enhanced Services 7.6.1 Drug Action Services 4 Solihull Pharmaceutical Needs Assessment 2015 – 2019 7.6.1.1 Needle Exchange 7.6.1.2 Supervised Consumption Service 7.6.2 Sexual Health Services 7.6.2.1 Birmingham & Solihull Chlamydia & Gonorrhoea Screening Programme (BeSure) in young people aged 15-24 7.6.2.2 Emergency Hormonal Contraception for women (aged 13 and over 7.6.3 Smoking Cessation Service 7.6.3.1 Nicotine Replacement Therapy (NRT) Service 7.6.4 Blood Borne Virus (BBV) Testing 7.6.5 Specialist Palliative Care Drugs Service 7.6.6 Seasonal Influenza Vaccination Service 7.6.7 Supply of Fosfomycin Service 7.6.8 Minor Ailments Scheme 8. Conclusions 8.1 Recommendations APPENDICES Appendix 1Terms of Reference and Steering Group Membership Appendix 2 Background Legislation Appendix 3 Key of MSOA’s Appendix 4 Pharmacy Survey Online Version Appendix 5 Pharmacy Survey Design Version Appendix 6 Pharmacy Stakeholder Questionnaire results APPENDIX 7 Patient Survey APPENDIX 8: Patient Survey Report Appendix 9 – Dissemination Matrix for Consultation Appendix 10 Pharmacy Details APPENDIX 11 Report on Consultation APPENDIX 12 References 5 Solihull Pharmaceutical Needs Assessment 2015 – 2019 Abbreviations and Glossary Abbreviations used in this document AUR .......................................................................................................................................... Appliance Use Review BAME ………………………………………………………………………………………… Black or Asian Ethnic Minority SHWB ..................................................................................................................... Solihull Health and Wellbeing Board CCG .............................................................................................................................. Clinical Commissioning Group CHD ........................................................................................................................................ Coronary Heart Disease COPD .............................................................................................................. Chronic Obstructive Pulmonary Disease DCLG ............................................................................................ Department of Communities and Local Government DH ............................................................................................................................ Department of Health [England] EHC .................................................................................................................... Emergency Hormonal Contraception EU .................................................................................................................................................... European Union GP .............................................................................................................................................. General Practitioner HWB ................................................................................................................................. Health and Wellbeing Board IDU ............................................................................................................................................... Injecting Drug User JSNA ....................................................................................................................... Joint Strategic Needs Assessment LPC ......................................................................................................................... Local Pharmaceutical Committee LPS ............................................................................................................................. Local Pharmaceutical Services MAS ........................................................................................................................................ Minor Ailments Scheme MUR .......................................................................................................................................... Medicines Use Review MSOA ..................................................................................................................................... Middle Super Output Area NHS ......................................................................................................................................... National Health Service NRT ............................................................................................................................. Nicotine Replacement Therapy OCU ........................................................................................................................................ Opiate and Crack Users PCT ................................................................................................................................................ Primary Care Trust PIS .......................................................................................................................... Prescription Intervention Service PNA ..................................................................................................................... Pharmaceutical Needs Assessment QOF ............................................................................................................................... Quality Outcomes Framework SAC ........................................................................................................................... Stoma Appliance Customisation SMBC ………………………………………………………………………………….Solihull Metropolitan Borough Council SPCD ............................................................................................................................ Specialist